Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinzhao Wang

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|January 11, 2021
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to GefitinibXiang Song, Xinzhao Wang, Zhaoyun Liu, et al.
Journal of Proteomics|December 1, 2023
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axisXiang Song, Xinzhao Wang, Xiqi Chen, et al.
Environmental Science and Pollution Research International|April 11, 2023
A safety assessment model of filling mining based on comprehensive weighting-set pair analysisDongmei Huang, Xinzhao Wang, Xikun Chang, et al.
BMC Complementary Medicine and Therapies|August 27, 2020
Cell metabolomics to study the function mechanism of Cyperus rotundus L. on triple-negative breast cancer cellsShuangshuang Ma, Fukai Wang, Caijuan Zhang, et al.
Frontiers in Oncology|July 31, 2023
Prediction of bone metastasis risk of early breast cancer based on nomogram of clinicopathological characteristics and hematological parametersZhaokun Tian, Chao Li, Xinzhao Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Effect of recombinant human p53 adenovirus (Ad-p53) combined with EGFR inhibitor gefitinib on the sensitivity of breast cancer MDA-MB-468 cells]Xinzhao Wang, Xiyun Guan, Leilei Wang, et al.
Technology in Cancer Research & Treatment|August 3, 2021
The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in ChinaXinzhao Wang, Lin Wang, Qian Yu, et al.
Frontiers in Pharmacology|April 3, 2025
Cyperotundone promotes chemosensitivity of breast cancer via SRSF1Chao Li, Lin Wang, Zhaoyun Liu, et al.
Scientific Reports|January 25, 2023
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathwayWenna Shao, Xinzhao Wang, Zhaoyun Liu, et al.
Frontiers in Oncology|August 5, 2022
A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local-Regional Recurrence After Breast-Conserving TherapyLuhao Sun, Wei Zhao, Fukai Wang, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|January 11, 2021
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to GefitinibXiang Song, Xinzhao Wang, Zhaoyun Liu, et al.
Journal of Proteomics|December 1, 2023
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axisXiang Song, Xinzhao Wang, Xiqi Chen, et al.
Environmental Science and Pollution Research International|April 11, 2023
A safety assessment model of filling mining based on comprehensive weighting-set pair analysisDongmei Huang, Xinzhao Wang, Xikun Chang, et al.
BMC Complementary Medicine and Therapies|August 27, 2020
Cell metabolomics to study the function mechanism of Cyperus rotundus L. on triple-negative breast cancer cellsShuangshuang Ma, Fukai Wang, Caijuan Zhang, et al.
Frontiers in Oncology|July 31, 2023
Prediction of bone metastasis risk of early breast cancer based on nomogram of clinicopathological characteristics and hematological parametersZhaokun Tian, Chao Li, Xinzhao Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2015
[Effect of recombinant human p53 adenovirus (Ad-p53) combined with EGFR inhibitor gefitinib on the sensitivity of breast cancer MDA-MB-468 cells]Xinzhao Wang, Xiyun Guan, Leilei Wang, et al.
Technology in Cancer Research & Treatment|August 3, 2021
The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in ChinaXinzhao Wang, Lin Wang, Qian Yu, et al.
Frontiers in Pharmacology|April 3, 2025
Cyperotundone promotes chemosensitivity of breast cancer via SRSF1Chao Li, Lin Wang, Zhaoyun Liu, et al.
Scientific Reports|January 25, 2023
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathwayWenna Shao, Xinzhao Wang, Zhaoyun Liu, et al.
Frontiers in Oncology|August 5, 2022
A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local-Regional Recurrence After Breast-Conserving TherapyLuhao Sun, Wei Zhao, Fukai Wang, et al.
Pageof 4